Artia Global Partners LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001937964

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 51 positions · Total reported value $495.64M · Top-10 concentration 62.7% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 44.3% · 13 new · 4 cut · 10 exited

Active Share (vs S&P 500): 98.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -16.4% · vs SPY -18.6% · Prev Value $541.86M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.3% · vs SPY -4.4% · Latest Value $495.64M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Artia Global Partners LP disclosed 51 equity positions with a combined reported value of $495.64M. The filing implies a focused portfolio: its ten largest positions account for 62.7% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were INSM ($67.23M), RVMD ($38.05M), ABVX ($36.07M). By sector, the heaviest allocations are Health Care 93.8%, Industrials 6.2%. Versus the prior quarter, allocation shifted toward Industrials (+4.2pp) and away from Health Care (-1.2pp), Other (-3.0pp).

Versus the prior quarter, Artia Global Partners LP opened 13 new positions, trimmed 4 and fully exited 10, a turnover rate of 44.3% of positions. The portfolio's overlap with the prior quarter was 62% of names.

The largest new positions opened in Q3 2026 were RVTY ($12.38M), BRKR ($6.72M), TMO ($5.14M).

Of the 10 positions fully exited versus the prior quarter, the largest were XBI ($15.82M), IONS ($11.45M), ALMS ($7.84M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • RVTY REVVITY INC · $12.38M
  • BRKR BRUKER CORP · $6.72M
  • TMO THERMO FISHER SCIENTIFIC INC · $5.14M
  • TXG 10X GENOMICS INC · $4.18M
  • MRNA MODERNA INC · $3.85M
  • GRAL GRAIL INC · $3.53M
  • TWST TWIST BIOSCIENCE CORP · $2.96M
  • CORT CORCEPT THERAPEUTICS INC · $2.07M

Fully Exited (vs previous quarter)

  • XBI SPDR SERIES TRUST · prev qtr: $15.82M
  • IONS IONIS PHARMACEUTICALS INC · prev qtr: $11.45M
  • ALMS ALUMIS INC · prev qtr: $7.84M
  • SION SIONNA THERAPEUTICS INC · prev qtr: $5.27M
  • PALI PALISADE BIO INC · prev qtr: $4.16M
  • XENE XENON PHARMACEUTICALS INC · prev qtr: $3.92M
  • CMPX COMPASS THERAPEUTICS INC · prev qtr: $839.21K
  • KOD KODIAK SCIENCES INC · prev qtr: $663.06K

Insider Transactions (Form 4)

Latest Artia Global Partners LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Artia Global Partners LP is an SEC-registered 13F filer based in Miami, FL, United States. As of Q2 2026 it reported 48 US equity positions with a combined value of $541.86M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: MIAMI, FL, United States
  • SEC registration: 801-125942 (status: Approved), registered 2022-06-23
  • Regulatory AUM (Form ADV): $778.89M as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 48 positions · $541.86M reported value (Q2 2026)
  • Top 10 holdings = 64.5% of reported value
  • Largest position: ABVX (ABIVAX SA) at 12.7%
  • Average position size: $11.29M

Sector Tilt

  • Health Care 94.9%
  • Industrials 2.0%
  • (classified holdings cover 97% of value)

Quarterly Activity

  • Q2 2026: 7 new, 11 added, 2 reduced, 8 exited
  • 28 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 93.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 589.05K $67.23M 13.56%
13.56%
Hold
2 185.39K $38.05M 7.68%
7.68%
Hold
3 364.27K $36.07M 7.28%
7.28%
Reduce
4 609.94K $34.61M 6.98%
6.98%
Add
5 2.21M $31.66M 6.39%
6.39%
Hold
6 29.74K $28.52M 5.75%
5.75%
Hold
7 398.49K $23.46M 4.73%
4.73%
Add
8 448.96K $18.19M 3.67%
3.67%
Hold
9 96.70K $17.25M 3.48%
3.48%
Add
10 98.38K $15.88M 3.21%
3.21%
Hold
11 65.12K $15.18M 3.06%
3.06%
Hold
12 165.74K $14.59M 2.94%
2.94%
Add
13 80.95K $12.38M 2.50%
2.50%
New
14 503.94K $12.26M 2.47%
2.47%
Hold
15 80.50K $11.70M 2.36%
2.36%
Add
16 27.10K $7.17M 1.45%
1.45%
Add
17 103.80K $6.72M 1.36%
1.36%
New
18 29.24K $6.60M 1.33%
1.33%
Add
19 161.18K $6.54M 1.32%
1.32%
Add
20 180.73K $5.89M 1.19%
1.19%
Hold
21 166.51K $5.59M 1.13%
1.13%
Add
22 7.61K $5.14M 1.04%
1.04%
New
23 464.44K $5.00M 1.01%
1.01%
Hold
24 129.80K $4.75M 0.96%
0.96%
Hold
25 70.70K $4.66M 0.94%
0.94%
Hold
26 96.28K $4.65M 0.94%
0.94%
Hold
27 24.99K $4.24M 0.86%
0.86%
Hold
28 46.30K $4.18M 0.84%
0.84%
New
29 17.74K $4.04M 0.81%
0.81%
Hold
30 50.52K $4.02M 0.81%
0.81%
Reduce
31 20.00K $3.85M 0.78%
0.78%
New
32 25.20K $3.53M 0.71%
0.71%
New
33 137.80K $3.46M 0.70%
0.70%
Hold
34 72.10K $3.31M 0.67%
0.67%
Hold
35 22.95K $3.23M 0.65%
0.65%
Hold
36 15.30K $2.96M 0.60%
0.60%
New
37 33.40K $2.78M 0.56%
0.56%
Hold
38 5.00K $2.71M 0.55%
0.55%
Hold
39 29.20K $2.18M 0.44%
0.44%
Hold
40 18.00K $2.07M 0.42%
0.42%
New
41 38.41K $1.91M 0.39%
0.39%
Hold
42 464.70K $1.52M 0.31%
0.31%
Reduce
43 334.40K $1.38M 0.28%
0.28%
New
44 5.80K $999.40K 0.20%
0.20%
New
45 553.74K $919.22K 0.18%
0.18%
Reduce
46 2.50K $728.08K 0.15%
0.15%
Hold
47 205.32K $496.88K 0.10%
0.10%
Hold
48 8.30K $486.55K 0.10%
0.10%
New
49 4.00K $356.12K 0.07%
0.07%
Hold
50 20.44K $262.30K 0.05%
0.05%
New

FAQ

What did Artia Global Partners LP buy in 2026-Q3?

In its 2026-Q3 13F filing, Artia Global Partners LP reported 51 equity positions worth $495.64M in aggregate; its largest disclosed positions were INSM ($67.23M), RVMD ($38.05M), ABVX ($36.07M).

How large is Artia Global Partners LP's portfolio?

Artia Global Partners LP reported $495.64M of long equity holdings across 51 positions as of 2026-Q3. Top-10 holdings account for 62.7% of reported value.

What is Artia Global Partners LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/artia-global-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →